Archive · 12 Dec 2025
Corona Remedies IPO Allotment Finalized, GMP at 27%
Corona Remedies, a pharmaceutical company, has finished giving out shares to investors who applied for its IPO.
The IPO was very popular, with many more people wanting to buy shares than were available.
The shares will start trading on the stock market on December 15, 2025.
Investors can check if they got shares through the BSE, NSE, or the registrar's website.
The company raised a lot of money from this IPO and plans to use it for various purposes.
The shares are currently trading at a higher price in the grey market, which means people are willing to pay more than the IPO price.
Corona Remedies IPO allotment finalized on December 11, 2025, with listing on December 15, 2025.
IPO received an overwhelming subscription of 144.54 times, with strong interest from all investor categories.
Shares to be listed on both BSE and NSE at the IPO price of ₹1,008 to ₹1,062 per share.
Proceeds to be used for corporate purposes and expansion, with ₹195 crore raised from anchor investors.
Investors can check allotment status online through BSE, NSE, or Bigshare Services' websites.
- Who
- Corona Remedies Ltd
- What
- IPO allotment finalized and listing details announced
- When
- Allotment finalized on December 11, 2025; listing on December 15, 2025
- Where
- Shares to be listed on BSE and NSE
- Why
- To raise funds for corporate purposes and expansion
Investors
Company
IPO Subscription
Investors
Investors showed extremely high interest, with the IPO receiving a 144.54 times subscription.
Company
The company successfully mobilized ₹195 crore from anchor investors and aims to leverage the IPO for growth.
- IPO Allotment Date
- December 11, 2025
- Listing Date
- December 15, 2025
- IPO Price Band
- ₹1,008 to ₹1,062 per share
- Total Funds Raised
- ₹655.37 crore
- Total Shares Issued
- 43,36,298 shares
- Minimum Retail Investment
- ₹3,144 (3 lots)
- Overall Subscription
- 144.54 times
- Retail Subscription
- 30.39 times
- QIB Subscription
- 293.80 times
- NII Subscription
- 220.18 times
- GMP Today
- ₹295 per share (27.78% premium)
- Listing Platform
- BSE and NSE
- Book-Running Lead Manager
- Not specified
- Registrar
- Bigshare Services Pvt. Ltd.
- Market Maker
- Not specified
Sources
Riddhi Display Equipments IPO allotment finalised: Latest GMP, guide to check allotment status online for SME IPO
Park Medi World IPO Day 3 LIVE: Last chance to buy - Check latest subscription status, IPO GMP - Should you apply?
Corona Remedies IPO Listing Price Prediction: Allotment Finalised, GMP At 27%, Check Listing Date
Nephrocare Health IPO Day 3: Last day to buy; check GMP, subscription status, and other details - Apply or not
Encompass Design share price makes stellar debut! Stock lists at ₹203.30 on NSE SME, rallying 90% from SME IPO price
Muted debut likely! Wakefit IPO GMP signals no listing gains- Check final subscription status, key details
Encompass Design India Delivers Strong Market Debut, Lists 90% Above IPO Price
